Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...

Kymera Therapeutics, Inc.: Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to ...

KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027 KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ongoing, with data expected by mid-2027 Fast Track de ...
Phys.org

Ancient fish used their lungs to hear underwater, scientists reveal

How did ancient fish perceive their environment in the deep sea? An international team led by scientists from the Natural History Museum of Geneva (MHNG) and the University of Geneva (UNIGE) reveals ...

178 qualifying conditions for weekly PIP payments

PIP is to help those with long-term physical or mental health condition or disability or those who have struggles to complete every day tasks ...
Healthline

How Does Propane Heat Affect COPD?

Propane fuel exposure can cause COPD and lead to symptom flare-ups, due to the toxic fumes and chemicals it contains. You can stay alert by watching for symptoms and get medical care and treatment if ...